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In vitro phosphorylation of platelet subcellular fractions revealed that most of the alkali-resistant phosphoproteins and the majority of pp60- 
were in the surface membrane fraction. An alkali-resistant phosphoprotein of about 100 kDa was also immune precipitated by an anti-phosphotyro- 
sine antibody and comigrated with gpIIIa. The phosphorylation of gpIIIa, but not gpIIb, was confirmed by the comparison of reduced and non- 
reduced gels, and this protein was phosphorylated exclusively on tyrosine. In contrast, both gpIIb and gpIIIa were phosphorylated when the purified 
complex was added to immunopurified, immobilised pp6& UC. A synthetic peptide with partial homology to a putative tyrosine phosphorylation 
site in the cytoplasmic domain of gpIIIa was phosphorylated by antibody-purified pp60-. Our results indicate that tyrosine-specific phosphoryla- 
tion of gpIIIa by pw” may play a role in the regulation of platelet function. 
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1. INTRODUCTION 
Platelets are small discoid cells which exhibit highly 
regulated adhesive properties and whose main physio- 
logical role is the prevention of blood loss by the for- 
mation of haemostatic plugs at the site of vascular 
injury. Activation by a wide variety of agonists which 
are released or become exposed during tissue damage 
results in adhesion to the vessel wall, cytoskeleton- 
driven shape changes, aggregation and ultimately 
release of granule contents [l]. 
plane of the membrane, and this appears to be an essen- 
tial part of the pathway leading to full activation, in- 
cluding adhesive and cytoskeletal changes [6]. 
Matrix receptors on the platelet membrane play a 
major role in activation and gpIIb-IIIa is the major 
platelet receptor for fibrinogen, although it will also 
bind to von Willebrand factor, fibronectin and vitro- 
nectin [ 1,2]. Lack of gpIIb-IIIa from platelet mem- 
branes leads to defective platelet function and bleeding 
disorders, such as Glanzmann’s thrombosthenia [3]. 
GpIIb-IIIa is a complex of two transmembrane glyco- 
protein subunits and belongs to the integrin superfam- 
ily of adhesion receptors, other members of which have 
fundamental roles in cell-matrix and cell-cell inter- 
actions [2,4]. In the resting platelet, the intact hetero- 
dimer is present on the cell surface but does not bind 
fibrinogen. However the binding site becomes available 
after activation, probably due to a conformational 
change in the subunits [5]. Receptor occupancy is con- 
current with the reorganisation of gpIIb-IIIa from a 
monodisperse to a clustered localisation within the 
Phosphorylation events are crucial to platelet activa- 
tion, and recently there have been several reports that 
many platelet proteins can be phosphorylated on tyro- 
sine residues. The major tyrosine kinase in platelet 
membranes is pp60c-s’c which represents 0.2-0.49’0 of 
the total protein [7-lo], however no substrates for this 
enzyme within the platelet have yet been identified. In 
other cells thea chain of another integrin, the fibronec- 
tin receptor, can be phosphorylated on tyrosine by the 
oncogenic homolog of pp60c-sK, pp60”‘“” [ 111. GpIIIa 
has extensive homology with other integrin B chains 
and is therefore a potential target for the platelet en- 
zyme. Since the phosphorylation of fibroblast integrin 
has been mapped to tyrosine 788, a residue conserved 
in the platelet gpIIIa chain [12], we have investigated 
whether there is any tyrosine-specific phosphorylation 
of gpIIb-IIIa in platelet membranes. 
2. MATERIALS AND METHODS 
2.1. Materials 
All chemicals were Analar grade purchased from B.D.H. and all 
other materials were purchased from Sigma unless otherwise stated. 
2.2. Preparation of membranes 
Correspondence address: S. Kellie, Dept. of Biochemistry. The 
Hunterian Institute, 35-43 Lincoln’s Inn Fields, London WCZA 
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Human platelets were isolated by differential centrifugation and 
different membrane fractions prepared by continuous flow elec- 
trophoresis as described in [13]. Three fractions were obtained: 
cytosol, intracellular membranes (ER and Golgi) and surface mem- 
branes. The intracellular and surface membrane components have 
been extensively characterised [13]. These were stor d at - 80°C until 
use. Protein determinations were performed using the BCA reagent 
(Pierce Ltd.) as described by the manufacturer. 
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2.3. Phosphorylation of membranes 
5Opg of protein were suspended in kinase buffer (26 mM Tris-HCl 
pH 7.5 containing 5 mM MgClr, 5 mM MnCl2 and 100 PM NasVO4 
and 5 &i [3zP]ATP (3000 Ci/mmol) (Amersham) was added to in- 
itiate the reaction. After incubation at 37°C for 10 min the reaction 
was terminated either by addition of 50~1 twice strength SDS reduc- 
ing Laemmli sample buffer [14] for immediate lectrophoresis or by 
addition of 1 ml ice-cold extraction buffer (PBS containing 1% 
nonidet P40, 5 mM EDTA, 10 mM NaF, 1 mM PMSF and lOO/rM 
NarV04) for subsequent immune precipitation. 
2.4. Alkali treatment of gels 
Following electrophoresis, the stained gels were autoradiographed 
and then treated with 1 M KOH for 2 h at 55°C as outlined [15]. 
2.5. Immune precipitation 
After extraction on ice for 20 min the lysed membranes were cen- 
trifuged (14 000 x g) for 5 min. The supernatants were pm&eared 
with sepharose CL4B and then 2 ~1 of antibody were added and in- 
cubated for 1 h at 4’C. 50 ~1 of a 50% suspension of rabbit anti- 
mouse Ig complexed protein A-trisacryl (Pierce) was added for 1 h. 
The immune complexes were then washed 4 times and resuspended in 
SDS sample buffer for electrophoresis. 
2.6. Western blotting 
10 pg of purified platelet fractions were electrophoresed and 
transferred to nitrocellulose and then immunoblotted with rabbit 
anti-pp60 [ 161. 
2.7. Acid hydrolysis and phosphoamino acid analysis of GpIIIa 
GplIb-IIIa was immunoprecipitated from “P-1abelled membranes 
by MAb MMr/356. electrophoresed and transferred to Immobilon-P 
membrane (Millipore) and autoradiographed to locate GpIIIa. The 
band was excised and the protein subjected to partial acid hydrolysis 
and thin layer electrophoresis at pH 3.5 [IS]. 
2.8. GpIIb-Ma and synthetic peptide phosphorylation by immo- 
bilked pp40c-“C 
Following immunoprecipitation of pp6@‘” from platelet mem- 
branes using the monoclonal antibody “*‘c(Ab-l) (Oncogene Science), 
the immune complex was washed extensively with kinase buffer and 
A 
ALK 
then 5 pg of purified gpIIb-IIIa (a kind gift from Dr. J. Gonzales, 
Madrid) or 50 cg of 12-mer (NHr-Ala-Ser-Lys-Tyr-Ile-Pro-Asn-Glu- 
Gly-Thr-Asp-Trp-COOH) were added. This is homologous to the 
region surrounding tyrosine 788, the phosphorylation site of integrin 
fit subunit which is partially conserved in gpIIIa. To initiate the reac- 
tion 35 #cl of kinase buffer containing 2.5 &i 32P-y-ATP was added. 
After incubation at 37’C for 20 min the sample was centrifuged and 
the supernatant subjected to SDS-PAGE (gpIIb-IIIa) or thin layer 
electrophoresis (12-mer peptide). 
2.9. Antibodies used 
Monoclonal anti-phosphotyrosine PY20 was purchased from ICN 
Biochemicals. Rabbit anti-pp60 was used as described [16] and 
monoclonal anti-pp60s”(Ab-1) was purchased from Oncogene 
Science. Monoclonal antibody MM2/356 which recognises the 
gpIIb-IIIa complex was generously provided by Dr. J.M. Wilkinson 
(this department). 
3. RESULTS 
3.1. Phosphorylation of purified platelet membrane 
fractions 
Proteins could be phosphorylated in vitro in each of 
the subcellular membrane fractions, however the 
cytosol contained fewer phosphoproteins (Fig. 1A). 
After alkali hydrolysis there was a reduction in the 
number of phosphopeptides, however the surface mem- 
brane fraction contained several alkali resistant bands, 
the major band being 55-60 kDa which was probably 
autophosphorylated pp60c-src. In addition other bands 
at 130, 100, 48, 40 and 36 kDa were visible (Fig. 1A). 
The presence of alkali-resistant phosphoproteins cor- 
related with the presence of pp60c-S’c in the subcellular 
fractions, with the surface membrane containing most 
of the pp60c-“” and the cytosol and intracellular mem- 
brane fractions containing barely detectable levels 
(Fig. 1B). 
B 
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Fig. 1. (A) Autoradiographs of total membrane protein labelled with [32P]ATP in purified platelet fractions before and after alkali treatmenf 
(alk). (B) Immunoblot of fractions transferred to nitrocellulose probed with anti-pp60. C, cytosol; IM, intracellular membranes; SM, surface 
membranes. 
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peptide of about 100 kDa which had the same electro- 
phoretic mobility as the tyrosine phosphorylated 
protein (Fig. 2), and there was a shift in the apparent 
molecular weight of the phosphorylated band which is 
characteristic of gpIIIa under nonreducing conditions 
(Fig. 3A). Coomassie blue staining showed that both 
gpIIb and gpIIIa were precipitated by the antibody, 
therefore the IIIa subunit of this complex was specifi- 
cally phosphorylated in the membrane (Fig. 3A). 
3.2. Phosphoamino acid analysis of gpIIIa 
The previous experiments indicated that a protein 
which comigrated with gpIIIa contained phosphotyro- 
sine. Phosphoamino acid analysis of 32P-labelled 
gpIIIa revealed that the phosphorylation was exclusive- 
ly on tyrosine (Fig. 3B). 
3.3. Phosphorylation of purified gpllb-IIIa by isolated 
pp60c-s’c 
To determine whether platelet pp60c-“‘c was capable 
of phosphorylating gpIIb-IIIa, this enzyme was im- 
mune precipitated from membranes and the immo- 
bilised complex added to purified gpIIb-IIIa. After 
phosphorylation the complex was spun off and the 
supernatant containing gpIIb-IIIa subjected to SDS- 
PAGE. Unlike the situation in membranes where only 
gpIIIa was phosphorylated, this use of purified enzyme 
and substrate resulted in the phosphorylation of both 
the IIb and IIIa peptides in complexes containing anti- 
pp60, but not in complexes containing nonimmune Ig 
(Fig. 4). The 60 kDa phosphoprotein comigrated with 
autophosphorylated pp60c-s*c. 
Fig. 2. lmmunoprecipitation of gpIIb-IIIa (IIB-IIIA) and phosphoty- 
rosine-containing proteins (PY20) from ‘*P-labelled surface mem- 
branes. CON, non-immune Ig. 10% reducing gel. 
The putative phosphotyrosinecontaining proteins 
were further characterised in the plasma membrane 
fraction by immunoprecipitation using the antiphos- 
photyrosine antibody PY20. Major bands of molecular 
weights approximately 66, 60, 45 and 40 kDa and also 
a protein of molecular weight approximately 100 kDa 
were precipitated (Fig. 2). Immunoprecipitation of the 
membranes by anti-gpIIb-IIIa resulted in a phospho- 
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Fig. 3. (A) Immunoprecipitation of gpIIb-IIIa from 32P-iabelled platelet membranes under reducing (R) and non-reducing (NR) conditions. ST, 
Coomassie blue staining showing both IIb and IIIa subunits; CON, non-immune Ig. (B) Phosphoamino acid analysis of 32P-labelled gpIIIa. 0, 
origin; PEP, unhydrolysed peptide; Y, phosphotyrosine; T, phosphothreonine; S, phosphoserine; P, free phosphate. 
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ig. 4. Phosphorylation of purified gpIIb-IIIa by immunoprecipi- ‘, t ted ~pfW_‘~ (A) Coomassie blue staining of gpIIb-IIIa in the phos- 
phorylation reactions. (B) Autoradiograph of dried gel showing 
phosphorylation of both gpIIb and gpIIIa in ppW~‘“-contairdng im- 
mune complexes (PP60) but not in lysates precipitated with non- 
immune Ig (CON). 
3.4. Phosphorylation of a synthetic peptide 
Since platelet gpIIIa has homology to ,& integrins, 
and has a conserved putative tyrosine phosphorylation 
site for pp60”+” [171, we investigated whether pp60cY” 
RSV-CEF Platelet 
+ 
0 
12-mer 
Fig. 5. Phosphorylation of a 12-mer synthetic peptide by immuno- 
precipitated pp60”-‘” from Rous sarcoma virus-transformed chick 
embryo fibroblasts (RSV-CEP) and by ppW-‘Ic immunoprecipitated 
from platelet surface membranes. 0, origin. 
can phosphorylate this site. pp60c-src was immune 
precipitated from platelet membranes and a 1Zmer 
synthetic peptide homologous to the sequence sur- 
rounding integrin fi chain tyrosine 788 used as a 
substrate in an in vitro phosphorylation reaction. This 
tyrosine residue is conserved in gpIIIa (tyrosine 747) 
[17]. Thin layer electrophoresis demonstrated that the 
peptide was phosphorylated by pp60c-src (Fig. 5). Con- 
trol experiments demonstrated that this peptide was 
phosphorylated by pp60v-s” precipitated from RSV- 
transformed fibroblasts but not from lysates immune 
precipitated with nonimmune serum (Fig. 5). 
4. DISCUSSION 
The rapid changes in platelet adhesiveness make it an 
excellent cell with which to investigate cell-matrix in- 
teractions. Whilst many of the integrin superfamily 
have been characterised in detail, there is still a paucity 
of information regarding the regulation of receptor- 
matrix interactions. It has been suggested that tyrosine- 
specific phosphorylation of the fli chain of the 
fibronectin receptor by pp60v-s’c leads to an alteration 
of the affinity of the receptor complex for fibronectin 
[12]. Platelets contain large amounts of the cellular 
homolog pp60c-src, and the IIIa subunit contains a 
tyrosine phosphorylation site similar to that of the 
fibroblast 81 integrin chain [17], therefore we have in- 
vestigated whether gpIIb-IIIa in platelet membranes 
can be phosphorylated by pp60’-““. Our results have 
demonstrated that in platelets most of the alkali- 
resistant bands and pp60c-src itself are in the plasma 
membrane fraction, indicating that this is the location 
of the major tyrosine kinase activity. The pattern of 
phosphorylation was similar to that previously reported 
for crude membranes, with pp60c-src the most intense 
band [7], although other higher molecular weight bands 
were also present. We have presented novel evidence 
that within membranes gpIIb-IIIa complex can be 
phosphorylated but only on the IIIa subunit, however 
in agreement with Findik et al. immunopurified 
pp60c-‘” phosphorylated both subunits of purified 
gpIIb-IIIa [18]. This may be due to a masking of the 
phosphorylation site of gpIIb in the membrane, or to 
a conformational change in the protein which exposes 
the phosphorylation site when purified or exposed to 
detergent. It is likely that the membrane phosphoryla- 
tion of gpIIIa described here more closely mimics the 
situation within whole platelets, however it is possible 
that the phosphorylation of gpIIb may also occur. 
Phosphoamino acid analysis revealed that gpIIIa was 
phosphorylated exclusively on tyrosine. Furthermore, 
PP6@-“” immunoprecipitated from platelet membranes 
phosphorylates a peptide similar to the putative tyro- 
sine phosphorylation site of gpIIIa, indicating that 
tyrosine 747 in gpIIIa may be a phosphorylation site. 
These results indicate that gpIIIa can be phosphory- 
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lated by pp60c~src in platelet membranes and this may be 
an important regulatory process in platelet function. 
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